Full Press Release Details
Rilonacept (IL-1 Trap) Granted FDA Priority Review for the Treatment of CAPS Regeneron’s first marketing application is accepted for review by the FDA.
REGN
Rilonacept (IL-1 Trap) Granted FDA Priority Review for the Treatment of CAPS Regeneron’s first marketing application is accepted for review by the FDA
Key Takeaway: Rilonacept (IL-1 Trap) Granted FDA Priority Review for the Treatment of CAPS Regeneron’s first marketing application is accepted for review by the FDA